Skip to main navigation
Skip to search
Skip to main content
Help & FAQ
Search by expertise, name or affiliation
Prot #AC-079A501: A PROspective, Observational, U.S.-based Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed with Mycosis Fungoides Cutaneous T-cell Lymphoma and Treated with Valchlor
Effective start/end date
Actelion Pharmaceuticals US, Inc.